# ClinicalTrials.gov record NCT07734792

> PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct07734792-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-29
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07734792-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07734792-tirzepatide-v1.json
- Content SHA-256: `3cf945f4e0d17f233492f133e904ac5f45b8f40e2ad6824c7dab99104a9386a7`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07734792 ([`ctg-observation-nct07734792-2026-07-29-16e12449ec7c`](#source-ctg-observation-nct07734792-2026-07-29-16e12449ec7c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct07734792-2026-07-29-16e12449ec7c`](#source-ctg-observation-nct07734792-2026-07-29-16e12449ec7c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct07734792-2026-07-29-16e12449ec7c`](#source-ctg-observation-nct07734792-2026-07-29-16e12449ec7c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07734792-2026-07-29-16e12449ec7c`](#source-ctg-observation-nct07734792-2026-07-29-16e12449ec7c))

## Sources

<a id="source-ctg-observation-nct07734792-2026-07-29-16e12449ec7c"></a>
- **ClinicalTrials.gov record NCT07734792 · retained source version 2026-07-29:16e12449ec7c16e6da927803b862ad70e818004c86e3c71791b515cb1f390ee2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07734792) (`ctg-observation-nct07734792-2026-07-29-16e12449ec7c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07734792." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07734792-tirzepatide-v1.json SHA-256: 3cf945f4e0d17f233492f133e904ac5f45b8f40e2ad6824c7dab99104a9386a7.